Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

Mechanisms of the tumour microenvironment and inflammation

Dr Alberto Mantovani – University of Milan, Italy
Mechanisms of the tumour microenvironment and inflammation ( Dr Alberto Mantovani – University of Milan, Italy )
20 Nov 2012

Patient led funding for clinical trials

Dr Ian Lewis – Tenovus, Cardiff, UK
Patient led funding for clinical trials ( Dr Ian Lewis – Tenovus, Cardiff, UK )
15 Nov 2012

Advances in haemato-oncological treatment options

Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK
Advances in haemato-oncological treatment options ( Prof Kenneth Anderson – Dana Farber Cancer Institute, Boston, UK )
15 Nov 2012

Benefits of partaking in clinical trials

Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK
Benefits of partaking in clinical trials ( Lt. Col. David Hamilton - Lord Kitchener National Memorial Fund and NHS National Cancer Peer Review, UK )
15 Nov 2012

Perception of inequalities in care and cancer registries

Sir Michael Richards – Department of Health, UK
Perception of inequalities in care and cancer registries ( Sir Michael Richards – Department of Health, UK )
15 Nov 2012

Highlights from the 4th EUTROC meeting

Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012

Histological and molecular sub types of ovarian cancer

Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands
Histological and molecular sub types of ovarian cancer ( Dr Jozien Helleman – Erasmus Medical Centre, Rotterdam, Netherlands )
15 Nov 2012

Development of clinical trials and biobanks

Prof Hani Gabra – Imperial College London, UK
Development of clinical trials and biobanks ( Prof Hani Gabra – Imperial College London, UK )
15 Nov 2012

The AKT pathway and chemotherapy resistant ovarian cancer

Dr Euan Stronach – Imperial College London, UK
The AKT pathway and chemotherapy resistant ovarian cancer ( Dr Euan Stronach – Imperial College London, UK )
15 Nov 2012

Ovarian cancer tumour banks and collaboration

Dr Elena Braicu - Charite University Hospital, Berlin, Germany
Ovarian cancer tumour banks and collaboration ( Dr Elena Braicu - Charite University Hospital, Berlin, Germany )
15 Nov 2012

Interplay between pathologies of ovarian cancer and genomics

Prof David Huntsman – University of British Columbia, Vancouver, Canada
Interplay between pathologies of ovarian cancer and genomics ( Prof David Huntsman – University of British Columbia, Vancouver, Canada )
15 Nov 2012

Biology of molecular sub types in ovarian cancer

Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia
Biology of molecular sub types in ovarian cancer ( Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia )
15 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation